iSiP
Latest round
- Series A
Last raised
- May 2025
Total raised
- $6M
Investors
- 3
About iSiP
Founded in 2022 and based in Tokyo, Japan, iSiP, Inc. operates a drug discovery DX platform that discovers and optimizes lead compounds using compound design AI. In May 2025, iSiP, Inc. The company is developing an AI-driven platform that integrates AI algorithms and physical simulations, enabling researchers to expedite drug development, identify novel compounds, and enhance the overall efficiency of pharmaceutical research. The firm’s platform accelerates the creation of new drugs and promotes the growth of a sustainable domestic research ecosystem.
Who invested in iSiP
3 investors across 2 rounds
See all investors in iSiP
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about iSiP
Who invested in iSiP?
iSiP has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has iSiP raised?
iSiP has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did iSiP last raise money?
iSiP's most recent round on record is a Series A, in May 2025.
What does iSiP do?
Founded in 2022 and based in Tokyo, Japan, iSiP, Inc.
Where is iSiP headquartered?
iSiP is headquartered in Tokyo, Japan.
Which VCs invest in companies like iSiP?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at iSiP's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like iSiP? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.